F. Casals

Phenotype, penetrance, and treatment of 133 cytotoxic T‐lymphocyte antigen 4–insufficient subjects

O. Elemento, T. Giese, A. Schulz, 2018, The Journal of allergy and clinical immunology.

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

X. Estivill, M. Juan, J. Yagüe, 2020, Journal of Clinical Immunology.

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

J. Gisbert, D. Bernardo, S. Fernández-Tomé, 2018, Mucosal Immunology.

Genome‐wide postnatal changes in immunity following fetal inflammatory response

R. Castelo, E. Sabidó, Núria Bonet, 2019, The FEBS journal.

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

M. López-Guerra, M. Rozman, J. Yagüe, 2023, Annals of the Rheumatic Diseases.

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

J. Gisbert, D. Bernardo, S. Fernández-Tomé, 2018, Mucosal Immunology.

Case report: Novel compound heterozygous IL1RN mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist

Núria Bonet, J. Aróstegui, S. Plaza, 2024, Frontiers in immunology.